Medical Net Income Statement

Financials in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Revenue	6,495	6,077	5,252	4,500	3,745	3,330
Revenue Growth (YoY)	11.56%	15.71%	16.71%	20.16%	12.46%	14.16%
Cost of Revenue	4,515	4,112	3,411	2,720	2,285	2,153
Gross Profit	1,980	1,965	1,841	1,780	1,460	1,177
Selling, General & Admin	1,833	1,864	1,524	1,396	1,000	845
Operating Expenses	1,835	1,866	1,542	1,401	1,010	846
Operating Income	145	99	299	379	450	331
Interest Expense	-12	-11	-6	-3	-1	-1
Interest & Investment Income	5	3	1	-	-	-
Currency Exchange Gain (Loss)	82	25	34	45	8	2
Other Non Operating Income (Expenses)	11	18	-7	10	-5	3
EBT Excluding Unusual Items	231	134	321	431	452	335
Gain (Loss) on Sale of Investments	352	352	-4	-40	84	-81
Gain (Loss) on Sale of Assets	1	-	5	2	-	-
Asset Writedown	-154	-154	-170	-143	-	-
Other Unusual Items	-301	-308	-1	-	-	-1
Pretax Income	129	24	151	250	536	253
Income Tax Expense	59	62	126	141	137	116
Earnings From Continuing Operations	70	-38	25	109	399	137
Minority Interest in Earnings	-31	-30	-20	7	-15	-8
Net Income	39	-68	5	116	384	129
Net Income to Common	39	-68	5	116	384	129
Net Income Growth	-	-	-95.69%	-69.79%	197.67%	63.29%
Shares Outstanding (Basic)	9	9	9	9	9	8
Shares Outstanding (Diluted)	9	9	9	9	9	8
Shares Change (YoY)	-0.79%	-1.34%	0.94%	2.40%	3.65%	-1.53%
EPS (Basic)	4.35	-7.62	0.55	12.95	43.88	15.28
EPS (Diluted)	4.35	-7.62	0.55	12.95	43.88	15.28
EPS Growth	-	-	-95.73%	-70.50%	187.19%	65.83%
Free Cash Flow	103	-211	87	410	340	378
Free Cash Flow Per Share	11.48	-23.64	9.62	45.76	38.85	44.77
Dividend Per Share	3.000	3.000	3.000	2.500	2.500	2.500
Dividend Growth	-	-	20.00%	-	-	233.33%
Gross Margin	30.48%	32.34%	35.05%	39.56%	38.98%	35.34%
Operating Margin	2.23%	1.63%	5.69%	8.42%	12.02%	9.94%
Profit Margin	0.60%	-1.12%	0.10%	2.58%	10.25%	3.87%
Free Cash Flow Margin	1.59%	-3.47%	1.66%	9.11%	9.08%	11.35%
EBITDA	222	175	352	440	479	355
EBITDA Margin	3.42%	2.88%	6.70%	9.78%	12.79%	10.66%
D&A For EBITDA	77	76	53	61	29	24
EBIT	145	99	299	379	450	331
EBIT Margin	2.23%	1.63%	5.69%	8.42%	12.02%	9.94%
Effective Tax Rate	45.74%	258.33%	83.44%	56.40%	25.56%	45.85%
Advertising Expenses	-	154	119	119	108	72

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.